The President in Charge of Venezuela, Juan Guaidó, informed the country that he has taken actions to correct and address the allegations of irregularities in the Monómeros Colombo-Venezolanos company through a decree introduced before the National Assembly to replace its Board of Directors and Management.
“The decree will be submitted for consideration in the next session of the National Assembly. I want to confirm, firmly, that I am going to defend the integrity of the assets of Venezuelans,” he reiterated through his Twitter account, assuring that he will not defend “any particularity” that has been proposed by no matter who.
The national president affirmed that he expects the support of the political parties and leaderships for the restructuring of the company.
“Venezuela wants to see leaders asking for transparency and taking firm action (…) It does not want to see them obstructing decisions, even requested by the independent and controller institution in the neighboring country to protect assets,” he said.
Guaidó affirmed that transparency in the face of Venezuela, accountability and progress are key to achieving an optimal result in the fight.
Furthermore, he added that the restructuring of the Board of Directors and Management of Monomeros, to adapt and optimize the processes and guarantee its independence, is part of the role that this Commission will have.
This Tuesday, October 5th, the President of the Delegate Commission of the National Assembly elected in 2015, Juan Guaidó, presented during the virtual parliamentary session a decree and a proposal to designate a new board of directors of Monómeros, this as part of the restructuring process of the company announced on September 14th.
The proposal presented to the Executive Committee is made up of two points: the appointment of a provisional general manager and the creation of a commission that will be in charge of defining the professional profiles that will be approved by Parliament of the General Manager of Monómeros and of all the members of the company’s board of directors, a Pequiven affiliate.